Drug Company Practices: Is COVID-19 a New Dawn for Human Rights Norms or Business as Usual?
Katrina Perehudoff and Tessa Jolan Jager
Drug company decisions about COVID-19 products reveal insights about the changing contours of responsible and rights-based corporate conduct in a health crisis. Those holding the intellectual property (IP)…